The glucose dependence of Akt-transformed cells can be reversed by pharmacologic activation of fatty acid beta-oxidation
- PMID: 15806154
- DOI: 10.1038/sj.onc.1208622
The glucose dependence of Akt-transformed cells can be reversed by pharmacologic activation of fatty acid beta-oxidation
Abstract
Activation of the oncogenic kinase Akt stimulates glucose uptake and metabolism in cancer cells and renders these cells susceptible to death in response to glucose withdrawal. Here we show that 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR) reverses the sensitivity of Akt-expressing glioblastoma cells to glucose deprivation. AICAR's protection depends on the activation of AMPK, as expression of a dominant-negative form of AMPK abolished this effect. AMPK is a cellular energy sensor whose activation can both block anabolic pathways such as protein synthesis and activate catabolic reactions such as fatty acid oxidation to maintain cellular bioenergetics. While rapamycin treatment mimicked the effect of AICAR on inhibiting markers of cap-dependent translation, it failed to protect Akt-expressing cells from death upon glucose withdrawal. Compared to control cells, Akt-expressing cells were impaired in the ability to induce fatty acid oxidation in response to glucose deprivation unless stimulated with AICAR. Stimulation of fatty acid oxidation was sufficient to maintain cell survival as activation of fatty acid oxidation with bezafibrate also protected Akt-expressing cells from glucose withdrawal-induced death. Conversely, treatment with a CPT-1 inhibitor to block fatty acid import into mitochondria prevented AICAR from stimulating fatty acid oxidation and promoting cell survival in the absence of glucose. Finally, cell survival did not require reversal of Akt's effects on either protein translation or lipid synthesis as the addition of the cell penetrant oxidizable substrate methyl-pyruvate was sufficient to maintain survival of Akt-expressing cells deprived of glucose. Together, these data suggest that activation of Akt blocks the ability of cancer cells to metabolize nonglycolytic bioenergetic substrates, leading to glucose addiction.
Similar articles
-
Short-term AMP-regulated protein kinase activation enhances insulin-sensitive fatty acid uptake and increases the effects of insulin on fatty acid oxidation in L6 muscle cells.Exp Biol Med (Maywood). 2010 Apr;235(4):514-21. doi: 10.1258/ebm.2009.009228. Exp Biol Med (Maywood). 2010. PMID: 20407084
-
AMP kinase activation with AICAR simultaneously increases fatty acid and glucose oxidation in resting rat soleus muscle.J Physiol. 2005 Jun 1;565(Pt 2):537-46. doi: 10.1113/jphysiol.2004.081679. Epub 2005 Mar 17. J Physiol. 2005. PMID: 15774530 Free PMC article.
-
AMPK activation is not critical in the regulation of muscle FA uptake and oxidation during low-intensity muscle contraction.Am J Physiol Endocrinol Metab. 2005 Mar;288(3):E592-8. doi: 10.1152/ajpendo.00301.2004. Epub 2004 Nov 16. Am J Physiol Endocrinol Metab. 2005. PMID: 15547141
-
Targeting the AMP-activated protein kinase for the treatment of type 2 diabetes.Curr Drug Targets Immune Endocr Metabol Disord. 2002 Jul;2(2):119-27. Curr Drug Targets Immune Endocr Metabol Disord. 2002. PMID: 12476786 Review.
-
A portrait of AKT kinases: human cancer and animal models depict a family with strong individualities.Cancer Biol Ther. 2004 Mar;3(3):268-75. doi: 10.4161/cbt.3.3.703. Epub 2004 Mar 11. Cancer Biol Ther. 2004. PMID: 15034304 Review.
Cited by
-
Fatty Acids Play a Critical Role in Mitochondrial Oxidative Phosphorylation in Effector T Cells in Graft-versus-Host Disease.Immunohorizons. 2024 Mar 1;8(3):228-241. doi: 10.4049/immunohorizons.2300115. Immunohorizons. 2024. PMID: 38441482 Free PMC article.
-
Impaired Autophagic Flux in Glucose-Deprived Cells: An Outcome of Lysosomal Acidification Failure Exacerbated by Mitophagy Dysfunction.Mol Cells. 2023 Nov 30;46(11):655-663. doi: 10.14348/molcells.2023.0121. Epub 2023 Oct 23. Mol Cells. 2023. PMID: 37867391 Free PMC article. Review.
-
Tumor microenvironmental nutrients, cellular responses, and cancer.Cell Chem Biol. 2023 Sep 21;30(9):1015-1032. doi: 10.1016/j.chembiol.2023.08.011. Epub 2023 Sep 12. Cell Chem Biol. 2023. PMID: 37703882 Review.
-
PUM1 Promotes Tumor Progression by Activating DEPTOR-Meditated Glycolysis in Gastric Cancer.Adv Sci (Weinh). 2023 Sep;10(27):e2301190. doi: 10.1002/advs.202301190. Epub 2023 Jul 19. Adv Sci (Weinh). 2023. PMID: 37469018 Free PMC article.
-
HSD17B4 methylation enhances glucose dependence of BT-474 breast cancer cells and increases lapatinib sensitivity.Breast Cancer Res Treat. 2023 Sep;201(2):317-328. doi: 10.1007/s10549-023-07013-y. Epub 2023 Jun 28. Breast Cancer Res Treat. 2023. PMID: 37378696
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous